These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29944110)

  • 21. Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase.
    Huang ZZ; Yu L; Huang P; Liang LJ; Guo Q
    PLoS One; 2017; 12(7):e0178231. PubMed ID: 28708860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man.
    Okada J; Ohshima N; Kubota-Koketsu R; Iba Y; Ota S; Takase W; Yoshikawa T; Ishikawa T; Asano Y; Okuno Y; Kurosawa Y
    J Gen Virol; 2011 Feb; 92(Pt 2):326-35. PubMed ID: 21068214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
    Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
    Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011.
    Ann J; Papenburg J; Bouhy X; Rhéaume C; Hamelin MÈ; Boivin G
    J Clin Virol; 2012 Jan; 53(1):88-92. PubMed ID: 22036039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural assignment of novel and immunodominant antigenic sites in the neutralizing antibody response of CBA/Ca mice to influenza hemagglutinin.
    Smith CA; Barnett BC; Thomas DB; Temoltzin-Palacios F
    J Exp Med; 1991 Apr; 173(4):953-9. PubMed ID: 1706753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of immunodominant sites in influenza hemagglutinin compromise antigenic variation and select receptor-binding variant viruses.
    Temoltzin-Palacios F; Thomas DB
    J Exp Med; 1994 May; 179(5):1719-24. PubMed ID: 8163950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasticity of Amino Acid Residue 145 Near the Receptor Binding Site of H3 Swine Influenza A Viruses and Its Impact on Receptor Binding and Antibody Recognition.
    Santos JJS; Abente EJ; Obadan AO; Thompson AJ; Ferreri L; Geiger G; Gonzalez-Reiche AS; Lewis NS; Burke DF; Rajão DS; Paulson JC; Vincent AL; Perez DR
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009-2012.
    Cai J; Wang X; Zhao B; Yao W; Wang X; Zhu Q; Zeng M
    J Med Virol; 2014 Jun; 86(6):1026-33. PubMed ID: 24523140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season.
    Chambers BS; Parkhouse K; Ross TM; Alby K; Hensley SE
    Cell Rep; 2015 Jul; 12(1):1-6. PubMed ID: 26119736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses.
    Chiba S; Hatta M; Pattinson D; Yasuhara A; Neumann G; Kawaoka Y
    Vaccine; 2023 Jan; 41(2):590-597. PubMed ID: 36517323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
    Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focused antibody response to influenza linked to antigenic drift.
    Huang KY; Rijal P; Schimanski L; Powell TJ; Lin TY; McCauley JW; Daniels RS; Townsend AR
    J Clin Invest; 2015 Jul; 125(7):2631-45. PubMed ID: 26011643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
    Smith G; Liu Y; Flyer D; Massare MJ; Zhou B; Patel N; Ellingsworth L; Lewis M; Cummings JF; Glenn G
    Vaccine; 2017 Sep; 35(40):5366-5372. PubMed ID: 28844407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany.
    Wedde M; Biere B; Wolff T; Schweiger B
    Int J Med Microbiol; 2015 Oct; 305(7):762-75. PubMed ID: 26416089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.
    Li Y; Bostick DL; Sullivan CB; Myers JL; Griesemer SB; Stgeorge K; Plotkin JB; Hensley SE
    J Virol; 2013 Sep; 87(17):9904-10. PubMed ID: 23824816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual.
    Katz JM; Webster RG
    Virology; 1988 Aug; 165(2):446-56. PubMed ID: 3407150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
    Broecker F; Liu STH; Sun W; Krammer F; Simon V; Palese P
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses.
    Huang JW; King CC; Yang JM
    BMC Bioinformatics; 2009 Jan; 10 Suppl 1(Suppl 1):S41. PubMed ID: 19208143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.